As a control, we used HL-60 cell line, a BCR-ABL1-negative acute leukemia, since normal healthy CD34+ bone marrow cells are not considered as a well-suited control cells for BP-CML cell lines harboring several genetical abnormalities. Here, CD34 is linked to acute leukemia.